Replies to post #64759 on Cannabis Science Inc (fka CBIS)

[JacqueAnon]

Not really, when you look at the fact there is heavy anticipation for more news about the product line and the expected acquisition of the cancer centre. The fact this didn't come out as fast as some hoped for may have scared off a percentage of impatient investors.

If solid good news or big developments on these topics (or others) come out, I'm pretty sure all the damage caused by the "bloodbath" will be healed and then some.

[gabbyco]

It hasn't lost .04 points it's gained 10 from the lows from January 4th. That's nearly 5 months...Again, you can't do math from were you sold unless it pertains to you. For someone that bought at .01 they are still up over 1000%.

[russ5555]

Since you are so big on news not moving CBIS anymore, take a look at the PR's from Jan to Mid Feb down the same .04 and all this came out. Know why........because the stock was consolidating right before the next run. Just take a look at the chart and you will see clear as day...

Tuesday, February 7, 2012
Cannabis Science Awaits Full Biopsy Report As Newest Series of Photos Shows Cancer Lesion Evidently Completely Killed & Hair Re-growth Begins On New Healthy Skin From 2nd Self-Administering Cancer PatientBusiness Wire (Tue, Feb 7)

Thursday, February 2, 2012
Cannabis Science Issues Corporate & Operations Guidance to Shareholders in Regards to Dividend, Market Potential, and Anecdotal ReportsBusiness Wire (Thu, Feb 2)
Cannabis Science Reports Success For 4th Brand New Self-Administering Cancer PatientBusiness Wire (Thu, Feb 2)

Wednesday, February 1, 2012
FDA Fast-Tracks New Cancer Drug for Skin Cancer While Cannabis Science Offers Topical Treatment for Basal Cell Carcinoma with No Apparent Side EffectsBusiness Wire (Wed, Feb 1)

Monday, January 30, 2012
Cannabis Science Presents Newest Photographs From 3rd Cancer Patient That Show Cancer Tumors Dying and Areas That Are Now Pain FreeBusiness Wire (Mon, Jan 30)

Thursday, January 12, 2012
Generex Biotechnology and Cannabis Science Look to Make Headway in Lucrative Cancer Drug MarketMarketwire (Thu, Jan 12)